BioAtla (BCAB) EPS (Basic) (2020 - 2026)
BioAtla's (BCAB) quarterly EPS (Basic) came in at $0.14 in Q2 2026, up 144.39% on a YoY basis from $0.06 in Q2 2025, and up 102.26% quarter-over-quarter from -$6.19 in Q1 2026.
Powered by 
Analysis
BioAtla (BCAB) EPS (Basic) (2020 - 2026) Analysis & Trends
BioAtla (BCAB) has reported EPS (Basic) for 7 consecutive years, with $0.14 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 144.39% year-over-year to $0.14; the trailing twelve-month figure through Jun 2026 stood at -$19.21 (down 1715.51% YoY), and the FY2025 full-year result was -$0.99, up 31.6% from the prior year.
- EPS (Basic) grew to $0.14 in Q2 2026 per BCAB's latest filing, from -$6.19 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.14 in Q2 2026 and bottomed at -$6.19 in Q1 2026.
- Historically, EPS (Basic) has averaged -$0.77 across 5 years, with a median of -$0.52 in 2023.
- The widest YoY moves for EPS (Basic): up 144.39% in 2026, down 1993.64% in 2026.
- Over 5 years, EPS (Basic) stood at -$0.71 in 2022, then advanced by 20.35% to -$0.56 in 2023, then surged by 42.62% to -$0.32 in 2024, then jumped by 51.68% to -$0.16 in 2025, then surged by 189.51% to $0.14 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered $0.14, -$6.19, and -$0.16 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -0.40 |
| 10 | BioAtla | 2.33 Mn | 2.33 Mn | - | 0.14 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.14 |
| Mar 31, 2026 | -6.19 |
| Dec 31, 2025 | -0.16 |
| Sep 30, 2025 | -0.23 |
| Jun 30, 2025 | -0.31 |
| Mar 31, 2025 | -0.30 |
| Dec 31, 2024 | -0.32 |
| Sep 30, 2024 | -0.22 |
| Jun 30, 2024 | -0.44 |
| Mar 31, 2024 | -0.48 |
| Dec 31, 2023 | -0.56 |
| Sep 30, 2023 | -0.70 |
| Jun 30, 2023 | -0.75 |
| Mar 31, 2023 | -0.58 |
| Dec 31, 2022 | -0.71 |
| Sep 30, 2022 | -0.69 |
| Jun 30, 2022 | -0.77 |
| Mar 31, 2022 | -0.65 |
| Dec 31, 2021 | -0.68 |
| Sep 30, 2021 | -0.68 |